Vibrance Medical Group — Beverly Hills, California

Vibrance Medical Group is a clinical research site located in Beverly Hills, California, United States 90212.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Vibrance Medical Group has participated in 1 clinical trials.

Therapeutic areas: Low Back Pain.

Sponsors: NEMA Research, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Beverly Hills

Browse all research sites in California · View every site in Beverly Hills

• Cedars-Sinai Hospital
• University of Southern California
• Westside Prostate Cancer Center, University of Southern California
• Century City Doctors Hospital
• Retina-Vitreous Associates Medical Group
• Tower Cancer Research Foundation
• Research Site
• GSK Investigational Site
• Beverly Hills Cancer Center
• Cedars-Sinai Medical Center
• Novartis Investigative Site
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vibrance Medical Group?

Vibrance Medical Group has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vibrance Medical Group conducted?

Vibrance Medical Group has 1 clinical trials on record. Their work covers Low Back Pain.

Is Vibrance Medical Group accredited by Crixeo Clinical Trials?

Vibrance Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vibrance Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.